FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1594865953> ?p ?o ?g. }

• W1594865953 endingPage "200" @default.
• W1594865953 startingPage "191" @default.
• W1594865953 abstract "Summary Given that aggressive DNA damaging chemotherapy shows suboptimal efficacy in chronic lymphocytic leukaemia (CLL), alternative therapeutic approaches are needed. Tumour necrosis factor‐related apoptosis‐inducing ligand (TRAIL) is able to induce tumour‐specific apoptosis. However, apoptosis might be inhibited by elevated levels of X‐linked inhibitor of apoptosis (XIAP). Use of XIAP‐inhibiting compounds might sensitize primary CLL cells towards TRAIL‐mediated apoptosis. A novel small molecule, compound A (CA), an inhibitor of XIAP, was used in combination with TRAIL to induce apoptosis in primary CLL cells ( n = 48). XIAP was significantly more highly expressed in primary CLL cells ( n = 28) compared to healthy B cells ( n = 16) ( P = 0·02). Our data obtained by specific knock‐down of XIAP by siRNA identified XIAP as the key factor conferring resistance to TRAIL in CLL. Combined treatment with CA/TRAIL significantly increased apoptosis compared to untreated ( P = 8·5 × 10 −10 ), solely CA ( P = 4·1 × 10 −12 ) or TRAIL treated ( P = 4·8 × 10 −10 ) CLL cells. CA rendered 40 of 48 (83·3%) primary CLL samples susceptible to TRAIL‐mediated apoptosis. In particular, cells derived from patients with poor prognosis CLL (ZAP‐70 + , IGHV unmutated, 17p‐) were highly responsive to this drug combination. Our highly‐effective XIAP inhibitor CA, in concert with TRAIL, shows potential for the treatment of CLL cases with poor prognosis and therefore warrants further clinical investigation." @default.
• W1594865953 created "2016-06-24" @default.
• W1594865953 creator A5018804552 @default.
• W1594865953 creator A5041065668 @default.
• W1594865953 creator A5049203352 @default.
• W1594865953 creator A5051152518 @default.
• W1594865953 creator A5058590537 @default.
• W1594865953 creator A5067845923 @default.
• W1594865953 creator A5076077834 @default.
• W1594865953 creator A5082067764 @default.
• W1594865953 creator A5087031072 @default.
• W1594865953 date "2010-11-23" @default.
• W1594865953 modified "2023-10-18" @default.
• W1594865953 title "Novel X-linked inhibitor of apoptosis inhibiting compound as sensitizer for TRAIL-mediated apoptosis in chronic lymphocytic leukaemia with poor prognosis" @default.
• W1594865953 cites W1966037066 @default.
• W1594865953 cites W1967051322 @default.
• W1594865953 cites W1986320887 @default.
• W1594865953 cites W1987506447 @default.
• W1594865953 cites W1996670401 @default.
• W1594865953 cites W1998198750 @default.
• W1594865953 cites W2017749679 @default.
• W1594865953 cites W2037978214 @default.
• W1594865953 cites W2038594427 @default.
• W1594865953 cites W2041941655 @default.
• W1594865953 cites W2042409437 @default.
• W1594865953 cites W2043135374 @default.
• W1594865953 cites W2043920292 @default.
• W1594865953 cites W2060138888 @default.
• W1594865953 cites W2069800916 @default.
• W1594865953 cites W2077703166 @default.
• W1594865953 cites W2079463756 @default.
• W1594865953 cites W2086329655 @default.
• W1594865953 cites W2113701382 @default.
• W1594865953 cites W2114675572 @default.
• W1594865953 cites W2117087670 @default.
• W1594865953 cites W2121184787 @default.
• W1594865953 cites W2123123035 @default.
• W1594865953 cites W2123513769 @default.
• W1594865953 cites W2125201177 @default.
• W1594865953 cites W2154011626 @default.
• W1594865953 cites W2156330379 @default.
• W1594865953 cites W2162441777 @default.
• W1594865953 cites W2165566753 @default.
• W1594865953 cites W2170935920 @default.
• W1594865953 cites W2328332463 @default.
• W1594865953 doi "https://doi.org/10.1111/j.1365-2141.2010.08426.x" @default.
• W1594865953 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21091905" @default.
• W1594865953 hasPublicationYear "2010" @default.
• W1594865953 type Work @default.
• W1594865953 sameAs 1594865953 @default.
• W1594865953 citedByCount "31" @default.
• W1594865953 countsByYear W15948659532012 @default.
• W1594865953 countsByYear W15948659532013 @default.
• W1594865953 countsByYear W15948659532014 @default.
• W1594865953 countsByYear W15948659532015 @default.
• W1594865953 countsByYear W15948659532016 @default.
• W1594865953 countsByYear W15948659532017 @default.
• W1594865953 countsByYear W15948659532018 @default.
• W1594865953 countsByYear W15948659532020 @default.
• W1594865953 countsByYear W15948659532021 @default.
• W1594865953 crossrefType "journal-article" @default.
• W1594865953 hasAuthorship W1594865953A5018804552 @default.
• W1594865953 hasAuthorship W1594865953A5041065668 @default.
• W1594865953 hasAuthorship W1594865953A5049203352 @default.
• W1594865953 hasAuthorship W1594865953A5051152518 @default.
• W1594865953 hasAuthorship W1594865953A5058590537 @default.
• W1594865953 hasAuthorship W1594865953A5067845923 @default.
• W1594865953 hasAuthorship W1594865953A5076077834 @default.
• W1594865953 hasAuthorship W1594865953A5082067764 @default.
• W1594865953 hasAuthorship W1594865953A5087031072 @default.
• W1594865953 hasBestOaLocation W15948659531 @default.
• W1594865953 hasConcept C17991360 @default.
• W1594865953 hasConcept C190283241 @default.
• W1594865953 hasConcept C203014093 @default.
• W1594865953 hasConcept C2777408456 @default.
• W1594865953 hasConcept C2777938653 @default.
• W1594865953 hasConcept C2778461978 @default.
• W1594865953 hasConcept C31573885 @default.
• W1594865953 hasConcept C33195913 @default.
• W1594865953 hasConcept C502942594 @default.
• W1594865953 hasConcept C55493867 @default.
• W1594865953 hasConcept C71924100 @default.
• W1594865953 hasConcept C86803240 @default.
• W1594865953 hasConcept C98424977 @default.
• W1594865953 hasConceptScore W1594865953C17991360 @default.
• W1594865953 hasConceptScore W1594865953C190283241 @default.
• W1594865953 hasConceptScore W1594865953C203014093 @default.
• W1594865953 hasConceptScore W1594865953C2777408456 @default.
• W1594865953 hasConceptScore W1594865953C2777938653 @default.
• W1594865953 hasConceptScore W1594865953C2778461978 @default.
• W1594865953 hasConceptScore W1594865953C31573885 @default.
• W1594865953 hasConceptScore W1594865953C33195913 @default.
• W1594865953 hasConceptScore W1594865953C502942594 @default.
• W1594865953 hasConceptScore W1594865953C55493867 @default.
• W1594865953 hasConceptScore W1594865953C71924100 @default.
• W1594865953 hasConceptScore W1594865953C86803240 @default.
• W1594865953 hasConceptScore W1594865953C98424977 @default.
• W1594865953 hasIssue "2" @default.

• next